Barclays Raises Numbers on C.R. Bard, Inc. (BCR); Potential Litigation Windfall

July 13, 2012 2:15 PM EDT
Get Alerts BCR Hot Sheet
Price: $231.85 -1.25%

Rating Summary:
    10 Buy, 17 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 22 | Down: 34 | New: 34
Trade BCR Now!
Join SI Premium – FREE
Barclays maintains an 'Underweight' on C.R. Bard, Inc. (NYSE: BCR) price target of $101.00 (from $87.00).

Analyst, Matthew Taylor, said, "We are updating our estimates, model, and price target for BCR to reflect the potential windfall from patent litigation with Gore...we continue to see BCR as well-run company but one that is tied to its markets and will be challenged to increase its growth and expand margins. While the windfall is a major positive, at these levels, we think the stock is already incorporating the benefit." (as of 3/31/12, Gore had deposited $887M with the District Court)

Taylor raises FY13 EPS estimate from $7.04 to $7.72.

For an analyst ratings summary and ratings history on C.R. Bard, Inc. click here. For more ratings news on C.R. Bard, Inc. click here.

Shares of C.R. Bard, Inc. closed at $105.61 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change

Related Entities


Add Your Comment